OverviewSuggest Edit

Fusion Antibodies is a CMO that offers a range of services covering all stages of therapeutic and diagnostic antibody development from target discovery to delivery of lead optimized commercial candidates suitable for cGMP scale up.

Fusion provides contract services include...

- Antibody Humanization services

- Antibody Engineering Services

- Antibody sequencing Services

- Protein Expression & Purification Services

- Monoclonal Antibody services BLAST & Standard

- cGMP Services

Fusion Therapeutics (a division of Fusion Antibodies) is committed to developing therapeutic antibodies and recombinant proteins to disease specific markers. Fusion Therapeutics is primarily focused on the key areas of oncology and angiogenesis where immunotherapeutic intervention has a proven track record. The company’s genomic mining and proteomic discovery strategy has resulted in the development of a growing pipeline of candidate drugs. Fusion Antibodies have a number of exciting targets undergoing validation with two targets currently in preclinical trials.

TypePrivate
Founded2001
HQBelfast, GB
Websitefusionantibodies.com

Locations

Fusion Antibodies is headquartered in
Belfast, United Kingdom

Location Map

Latest Updates

Employees (est.) (Apr 2020)39(+9%)
Revenue (FY, 2019)£2.2 M(-18%)
Cybersecurity ratingBMore

Key People/Management at Fusion Antibodies

Simon Douglas

Simon Douglas

Chairman of the Board
Paul Kerr

Paul Kerr

CEO
Richard Buick

Richard Buick

CTO
James Fair

James Fair

CFO
Sonya Ferguson

Sonya Ferguson

Non-Executive Director
Colin Walsh

Colin Walsh

Non-Executive Director
Show more

Fusion Antibodies Office Locations

Fusion Antibodies has an office in Belfast
Belfast, GB (HQ)
1 Springbank Road Springbank Industrial Est
Show all (1)

Fusion Antibodies Financials and Metrics

Summary Metrics

Founding Date

2001

Fusion Antibodies total Funding

$2.5 m

Fusion Antibodies latest funding size

$2.50 m

Time since last funding

13 years ago

Fusion Antibodies investors

Fusion Antibodies's latest funding round in July 2007 was reported to be $2.5 m. In total, Fusion Antibodies has raised $2.5 m
Show all financial metrics

Fusion Antibodies Revenue

Embed Graph
View revenue for all periods
Fusion Antibodies's revenue was reported to be £2.18 m in FY, 2019
GBP

Revenue (FY, 2019)

2.2m

Gross profit (FY, 2019)

804.0k

Gross profit margin (FY, 2019), %

36.8%

Net income (FY, 2019)

(1.3m)

EBIT (FY, 2019)

(1.5m)

Cash (31-Mar-2019)

2.0m
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

609.3k455.9k461.1k436.9k492.3k435.2k405.0k723.0k1.5m1.9m2.7m2.2m

Revenue growth, %

79%

Cost of goods sold

802.9k255.2k248.6k196.3k298.7k361.7k324.2k365.3k618.1k952.5k1.2m1.4m

Gross profit

(193.6k)200.7k212.4k240.6k193.6k73.5k80.8k357.7k863.2k961.5k1.5m804.0k
GBPFY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

8.8k19.4k20.8k369.5k62.1k165.3k436.8k127.9k318.5k126.2k45.1k129.0k139.1k103.6k413.9k285.7k4.5m2.0m

Accounts Receivable

198.0k151.5k189.4k99.4k263.5k89.6k92.1k86.5k205.3k241.7k510.0k510.9k726.3k

Inventories

10.9k32.7k39.0k43.6k70.3k81.8k242.7k

Current Assets

23.2k110.7k198.9k645.4k384.0k645.3k783.7k508.5k565.5k563.8k287.6k248.3k269.2k309.0k691.6k930.0k5.5m3.3m
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(815.8k)(1.1m)(1.3m)(960.2k)(533.9k)(752.2k)(468.7k)(113.5k)1.2m120.0k(699.9k)

Cash From Operating Activities

346.6k(37.4k)77.2k(1.1m)

Cash From Investing Activities

(1.4m)

Cash From Financing Activities

(496.0)(615.0)4.6m(27.7k)
GBPFY, 2002

Financial Leverage

1.6 x
Show all financial metrics

Fusion Antibodies Cybersecurity Score

Cybersecurity ratingPremium dataset

B

86/100

SecurityScorecard logo

Fusion Antibodies Online and Social Media Presence

Embed Graph

Fusion Antibodies Blogs

Fusion Antibodies Frequently Asked Questions

  • When was Fusion Antibodies founded?

    Fusion Antibodies was founded in 2001.

  • Who are Fusion Antibodies key executives?

    Fusion Antibodies's key executives are Simon Douglas, Paul Kerr and Richard Buick.

  • How many employees does Fusion Antibodies have?

    Fusion Antibodies has 39 employees.

  • What is Fusion Antibodies revenue?

    Latest Fusion Antibodies annual revenue is £2.2 m.

  • What is Fusion Antibodies revenue per employee?

    Latest Fusion Antibodies revenue per employee is £55.9 k.

  • Who are Fusion Antibodies competitors?

    Competitors of Fusion Antibodies include Addiction Campuses of America, Cmed and Tissue Regenix Group.

  • Where is Fusion Antibodies headquarters?

    Fusion Antibodies headquarters is located at 1 Springbank Road Springbank Industrial Est, Belfast.

  • Where are Fusion Antibodies offices?

    Fusion Antibodies has an office in Belfast.

  • How many offices does Fusion Antibodies have?

    Fusion Antibodies has 1 office.